Stockscreener 앱 받기
4.09
0.49%
-0.02
시간 외 거래:
4.10
0.010
+0.24%
Lifemd Inc 주식(LFMD)의 최신 뉴스
LifeMD Appoints Atul Kavthekar as CFO and Expands Leadership Team to Drive AI-First Healthcare Growth 1 - Minichart
LifeMD Announces CFO Transition and Expanded Leadership Team - TipRanks
LifeMD (NASDAQ: LFMD) installs new CFO and expands leadership team - Stock Titan
LifeMD appoints Atul Kavthekar as CFO - MSN
LifeMD (LFMD) to Participate in B. Riley's Virtual Meeting on Ma - GuruFocus
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LifeMD names Atul Kavthekar as CFO, announces leadership changes By Investing.com - Investing.com South Africa
LifeMD, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Lifemd, Inc. Announces Executive Appointments - marketscreener.com
LifeMD shares are trading higher after the co... - Benzinga
LifeMD Inc announced appointment of Atul Kavthekar as chief financial officer - marketscreener.com
LifeMD names Atul Kavthekar as CFO, announces leadership changes - Investing.com
LifeMD (NASDAQ:LFMD) Raised to Outperform at Mizuho - MarketBeat
LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer - TradingView
New CFO, CMO and business chief signal AI-first push at LifeMD - Stock Titan
This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
Mizuho upgrades LifeMD stock rating on weight-loss outlook - Investing.com Nigeria
Mizuho upgrades LifeMD stock rating on weight-loss outlook By Investing.com - Investing.com Canada
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings - simplywall.st
LifeMD (NASDAQ:LFMD) Upgraded to Hold at Wall Street Zen - MarketBeat
H.C. Wainwright raises LifeMD stock price target to $10 on results - Investing.com Nigeria
HC Wainwright Issues Positive Forecast for LifeMD Earnings - MarketBeat
A Look At LifeMD (LFMD) Valuation After Profitability Return And 2026 Growth Guidance - Yahoo Finance
LifeMD (LFMD) Valuation Check After Earnings Beat Guidance Update And Wegovy Partnership - simplywall.st
LifeMD, Inc. (LFMD) reports Q4 loss, tops revenue estimates - MSN
LifeMD (LFMD) Analyst Rating: Freedom Capital Markets Raises Pri - GuruFocus
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - TradingView
Freedom Capital Markets raises LifeMD stock price target on forecast boost By Investing.com - Investing.com South Africa
Freedom Capital Markets raises LifeMD stock price target on forecast boost - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD) - The Globe and Mail
LifeMD surges 11.5% on Q4 earnings beat, FY guidance By Investing.com - Investing.com Nigeria
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha - Seeking Alpha
LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101 - Minichart
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00 - MarketBeat
LifeMD (LFMD): HC Wainwright Raises Price Target While Maintaini - GuruFocus
LifeMD (LFMD) Trailing Losses Narrow To US$14.6m Challenging Bearish Profitability Narratives - Sahm
Cantor Fitzgerald Maintains Overweight on LifeMD, Inc. (LFMD) March 2026 - Meyka
LifeMD 10-K: Telehealth revenue $194.1M, Net income $15.62M - TradingView
LifeMD Issues 2026 Outlook Amid Strong 2025 Growth - The Globe and Mail
LifeMD (NASDAQ: LFMD) grows 2025 telehealth revenue 25% as losses narrow - Stock Titan
LifeMD (LFMD) Soars After Strong Q4 Results and Positive Outlook - GuruFocus
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target By Investing.com - Investing.com Australia
LifeMD soars as Cantor Fitzgerald reportedly reiterates Overweight rating following solid Q4 print - Seeking Alpha
Cantor Fitzgerald reiterates Overweight on LifeMD stock, $15 target - Investing.com
BTIG Research Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD (LFMD) Receives Analyst Rating Reiteration from BTIG | LF - GuruFocus
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
5.94%
자본화:
|
볼륨(24시간):